Abstract Calcium hydroxide (CH) loaded poly(DL-lactide-co-glycolide) acid (PLGA) microspheres (MS) might be used for apexification requiring a sustained release of Ca 2? . than W/O/W-produced MS (statistically significant differences; P \ 0.05). In conclusion, the CH-PLGA-MS were successfully formulated; the technique of formulation influenced the size, encapsulation efficiency and release profile. The MS were better sustained release system than the CH paste.
Introduction
Apexification is the induction of apical closure to produce favorable conditions for conventional root canal filling [1] . Calcium hydroxide, Ca(OH) 2 is widely used for apexification treatment because of its ability to induce mineral tissue formation and apical closure [1, 2] . The Ca(OH) 2 is a versatile compound because of its both antibacterial activity and ability to induce mineral tissue formation. When Ca(OH) 2 releases hydroxyl ions (OH -), a local increase of pH (*12.5) occurs in the tissues causing damage to bacterial DNA and cytoplasmic membrane resulting in cell death. At the same time, the high alkaline environment and released calcium ions (Ca 2? ) induce cellular activity promoting mineral tissue formation [3] [4] [5] . Because the apexification is a long-term treatment, it requires sustained release of Ca 2? from the Ca(OH) 2 and usually to achieve that condition, the Ca(OH) 2 is replaced on multiple appointments [2] . Thus a biodegradable sustained drug delivery system (SDDS) loaded with Ca(OH) 2 [8] . Despite the few approaches to research polymer-based MS for Ca 2? sustained release, the studies have ignored the use of a biomaterial with advantageous physicochemical properties for such purpose: the poly(DL-lactide-co-glycolide) acid (PLGA). The PLGA is a biodegradable and biocompatible polymer approved for human use by the FDA; its degradation in tissues initiates by hydrolysis of the ester linkages of the polymer chain giving the innocuous lactic acid and glycolic acid [9] . Acting as matrix of a MS, the PLGA might entrap a biomolecule that will be released while the polymer degradation occurs; this action results in a sustained release that depends on PLGA properties but also on the characteristics of the MS [10, 11] . Accordingly, it was suggested to explore the formulation of a sustained release system of Ca(OH) 2 loaded PLGA-MS for apexification.
The aim of this study was to formulate and characterize Ca(OH) 2 loaded PLGA-MS (CMS). Physical properties of the CMS were evaluated and Ca 2? release profile of the CMS and a control Ca(OH) 2 paste were compared.
Materials and methods
Poly(DL-lactide-co-glycolide) acid (ratio lactide:glycolide 75/25; mol wt 66,000-107,000 kDa), dichloromethane anhydride (DCM) C99.8 % solvent, Polyethylene glycol (PEG; Mn 400) and polyvinyl alcohol (PVA) (87.90 % hydrolyzed) were purchased from Sigma-Aldrich (St Louis, MO,USA). Calcium hydroxide was purchased from Viarden (Mexico City, DF, MX). All reagents were of analytical grade.
Preparation of the MS

Oil-in-water single-emulsion solvent evaporation technique (W/O)
The O/W technique was based and adapted from methodologies previously reported [12, 13] . Briefly, 20 mg Ca(OH) 2 and 200 mg PLGA were added into a 10 mL glass tube containing 2 mL DCM, this oil phase (drug/matrix dispersion) was vortexed with a Maxi Mix II vortex (Thermo Scientific, Pittsburgh, PA, USA) at maximum speed for 3 min. Immediately after that, the oil phase was added drop-wise into a 250 mL glass baker containing a 100 mL 1 % PVA (continuous phase) under stirring at 800 rpm (25°C) (Corning PC 4200 stirring hot plate, Corning, NY, USA). After that 100 mL of distilled water was added. Then, the stirring continued for 3 h to promote evaporation of DCM. After finishing the stirring, the formed MS were recovered by filtration through a filter paper (2 lm Filter Paper Ahlstrom, Monterrey, NL MEX) and were washed copiously with distilled water. Finally the MS were freeze-dried (Freeze Dry System Freezone 6, Labconco, Kansas City, MI, USA) for 4 h and stored at 4°C until its characterization and evaluation of Ca 2? release. The Ca(OH) 2 loaded MS were identified as oCMS. Blank control MS were produced following the same method without Ca(OH) 2 .
Water-in-oil-in-water method double-emulsion solvent evaporation technique (W/O/W)
The WOW procedure was based and adapted from techniques already reported [12, 13] . Briefly, a 20 mg/mL Ca(OH) 2 dispersion was prepared with double distilled water. This dispersion and 200 mg PLGA were added into a 10 mL glass tube containing 2 mL DCM, this oil phase (drug/matrix dispersion) was vortexed with a Maxi Mix II vortex (Thermo Scientific, Pittsburgh, PA, USA) at maximum speed for 3 min. After that, the procedure was performed as described in the paragraph above (see O/W process). The Ca(OH) 2 loaded MS were identified as wCMS. Blank control MS were produced with the same method without Ca(OH) 2 .
Characterization of the MS
Morphology of the MS
Morphology was observed using 1-2 mg MS. They were put on an adhesive tape, and then coated with gold (20 mA for 4 min). The gold-coated MS were observed by a scanning electronic microscope (Philips XL-30, Philips, Hillsboro, OR, USA).
Particle size analysis of the MS
MS were imaged at 1009 using a light microscope with a digital camera (Olympus, Center Valley, PA, USA). Images were analyzed with ImageJ Software (Version 1.45, National Institutes of Health, Bethesda, MD, USA); one Odontology (2016) 104:318-323 319 hundred of MS were measured and its average diameter was calculated. A Mann-Whitney U test was applied to identify a possible statistical significant difference between CMS and blank MS as well as between oCMS and wCMS. Statistical significance was set at P \ 0.05.
Encapsulation efficiency (E e )
To calculate the E e , Ca(OH) 2 -loaded MS were dissolved in 1 M NaOH.
In this dissolution, a calcium colorimetric marker (Calcio Arsenazo III, Bio Simex, Guadalajara, JAL, MEX) was added for 5 min to react with Ca 2? . The reagent caused a blue color in the samples; thus absorbance of the samples was measured by a UV-Vis system at 650 nm (Cary 50 UV-Visible Spectroscopy System, Agilent Technologies, Mexico City, MEX). A calibration curve was previously performed to obtain the calcium concentration in relation to absorbance values. E e was calculated as the ratio of the experimental loading to the theoretical loading, of the drug in the microspheres.
Ca 21 release
Twenty mg of either oCMS or wCMS was suspended into 1 mL deionized water in an Eppendorf tube (1.5 mL) and incubated at 37°C for 30 days and shook at 150 rpm (Incu-Shaker Mini, Benchmark Scientific; Edison, NJ, USA). The deionized water of the Eppendorf tubes was collected at different times; then 1 mL fresh deionized water was added in the Eppendorf tube containing the CMS. For Ca 2? measuring, the Ca 2? in the collected supernatant was marked with a calcium colorimetric marker (Calcio Arsenazo III, Bio Simex, Guadalajara, JAL, MEX) and measured by a UV-Vis system at 650 nm (Cary 50 UV-Visible Spectroscopy System, Agilent Technologies, Mexico City, MEX). Ca 2? concentration was calculated from the absorbance in the basis of a calibration curve performed previously. Ca 2? release of experimental groups was compared with a Ca 2? release of a control paste prepared with Ca(OH) 2 and PEG 400 (1.5 mg/10 lL). The Ca(OH) 2 paste was incubated in a 1.5 cm length dialysis tubing cellulose membrane (Avg. flat width 10 mm; typical molecular weight cut-off = 14,000; Sigma-Aldrich, St. Louis, MO, USA) with a seal in each extremity. The membrane was used only for the control paste to avoid its immediate dispersion in the deionized water. The membrane with the paste was suspended into 1 mL deionized water in an Eppendorf tube (1.5 mL) and incubated at 37°C for 30 days and shook at 150 rpm. The measurement of Ca 2? was identically as described for the CMS. All experiments were done in triplicate. The nonparametric Kruskal-Wallis Test was applied to identify possible statistically significant differences between Ca 2? release profiles of control and CMS. A difference was considered to be significant if the probability of its occurring by chance alone was \5 % (P \ 0.05).
Results
CMS with a similar spherical morphology were obtained with two emulsion solvent evaporation techniques. The CMS exhibited different topographical characteristics depending on the preparation method (Fig. 1) . The oCMS showed an average diameter of 18.63 ± 7.23 lm, while the wCMS showed a diameter of 15.25 ± 7.36 lm. No statistical difference in diameter was found between CMS and blank MS. Significantly statistical difference was noticed (P \ 0.001) between average diameter of oCMS and wCMS. Calculation of E e was 24 % for oCMS, while it was 11 % for the wCMS. Compared with the control paste, the CMS showed a lower and longer Ca 2? releasing activity. The control paste released 811.2 ± 26.3 lg/mL (100 % of release) after 6 days of evaluation and no more Ca 2? was detected after that time. On the opposite, the CMS showed a Ca 2? releasing activity for 30 days. The total released Ca 2? was 590.1 ± 89.0 lg/mL for the oCMS and 297.9 ± 50.6 lg/mL for the wCMS; that represented 76.6 and 90.9 % of Ca 2? for the oCMS and wCMS, respectively.
Discussion
The formulation of CMS by the solvent extraction/evaporation method was explored in the study. In this method a drug/matrix oily dispersion is partitioned into microdroplets when it is added in an aqueous phase under shear forces. Then, extraction/evaporation of the solvent induces PLGA crystallization transforming the microdroplets into solid MS. The O/W and W/O/W techniques, two variants of the method, were used to formulate the CMS.
They differed in the physical presentation of the Ca(OH) 2 for the dispersed phase, which was used as a powder for the O/W and diluted in distilled water for the W/O/W techniques. The wCMS showed a rough like-porous surface while the oCMS showed a smooth surface; the average diameter of the MS was another property varying between the wCMS and the oCMS, these latter were the largest ones. The size of the MS depends on factors controlled by the formulation technique, for instance speed of stirring, temperature of the aqueous phase, or mass content in the dispersed phase [12] . In this study, the phase for the O/W presented larger solid content than the dispersed phase for the W/O/W. In that condition, a dispersed phase is more resistant against the shear forces causing its partitioning into droplets, and consequently larger MS are produced [14] . The oCMS entrapped over twice Ca(OH) 2 than the wCMS. Higher E e in oCMS is explained because higher DMC volume in the O/W dispersed phase reduces the flux of the used biomolecule (Ca(OH) 2 in our case) to aqueous phase during solvent extraction/evaporation, and also accelerate PLGA crystallization with a consequent increase in the entrapment of the drug [15] . Ca(OH) 2 is an hydrophilic molecule that easily might go to the aqueous phase from the dispersed phase causing a low E e . It was determined whether CMS released lower Ca 2? compared to Ca 2? released from a Ca(OH) 2 paste formulated with PEG 400, a fluid polymer used to promote slow and sustained release of Ca 2? [2, 16, 17] . The paste showed a burst release of 42.6 % Ca 2? after 1 day of evaluation; then the paste showed a release of 86.3 % Ca 2? after 3 days and finally it showed a release of 100 % Ca 2? after 6 days. The PEG is a highly hydrophilic polymer, thus it was rapidly dissolved in the PBS under our experimental conditions resulting in a fast release of the Ca 2? . The CMS behaved as a more efficient slow and sustained release system compared to the Ca(OH) 2 paste indeed. In the CMS, the Ca(OH) 2 was entrapped into the PLGA matrix during the MS formulation and it was released in a slow and sustained manner because of the gradual degradation of the polymer matrix during the evaluation time. The CMS kept a Ca 2? release for 30 days. During first 9 days of evaluation a similar Ca 2? release profile was noticed for both oCMS and wCMS, but since day 12th, the Ca 2? release profiles behaved different in both CMS. The difference between release profiles to the surface properties of the MS was correlated. A rough like-porous surface favors a rapid drug release because fluids penetrate easier into the MS matrix and facilitates degradation of PLGA, releasing the entrapped drug; on the contrary, a smooth surface delays drug release [18, 19] . Moreover, wCMS loaded less Ca(OH) 2 , as demonstrated by the percentage of E e , and this was reflected on the release profile (Fig. 2) .
To our knowledge, no other study has investigated Ca(OH) 2 Although the CAMS and the CMS are different in their characteristics, both systems showed a better sustained release profile when compared to a Ca(OH) 2 paste.
The PLGA was chosen to produce the MS because of its biocompatibility and biodegradability. The CMS were a micro-granular material ad hoc to be introduced into a root canal by a double-ended spatula for cement. When needed, the CMS might be easily removed from the root canal by flushing with distilled water followed by aspiration. If the CMS were located at extra-radicular area-as might occur for apexification-they will be biodegraded by action of the tissue fluid [12] . Thus the CMS might be placed into the root canal at apical level intending a single application of a SDDS. Using CMS might overcome disadvantages of CH paste for apexification such as replacement of paste requiring multiple visits but also risk of root fracture by Ca(OH) 2 dressing [20] [21] [22] . This study shows methodological limitations. Evaluation time for 30 days was suitable to explore the release profile but it was short for a clinical reality; also the evaluation was short to know the time in which both oCMS and wCMS releases the total content of Ca 2? . Also, it was obtained an E e three times lower than the total amount of Ca(OH) 2 used in the formulation of the CMS, the technique should improve to get a higher E e . The CH releases Ca 2? and OH -, this study focused on the measuring of the Ca 2? because the CMS were suggested as a DDS for apexification. But it cannot be ignored that the OH -might have an impact on the CMS. The OH -increases the pH of the local environment [3, 5] ; hence the increment of pH could have an effect on the conditions that were used to evaluate the CMS. At the same time, the degradation of PLGA promotes an acidification of the local environment that might impact on the alkalinity of the medium [23] , but OH -could reduce such impact. If any of this hypothetical mechanism occurred in the experiments, it could not be considered an important issue for the evaluation because the PBS was refreshed for every evaluation point time.
In conclusion, CMS were successfully formulated; the techniques used to produce them influenced their characteristics. The CMS showed a size suitable for its application into a root canal. The CMS showed a Ca 2? sustained releasing activity for 30 days and it was better than that of the Ca(OH) 2 paste.
